| 000 | 01511 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250511180057.0 | ||
| 264 | 0 | _c19920702 | |
| 008 | 199207s 0 0 eng d | ||
| 022 | _a0085-2538 | ||
| 024 | 7 |
_a10.1038/ki.1992.28 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWatson, M L | |
| 245 | 0 | 0 |
_aEffects of angiotensin converting enzyme inhibition in adult polycystic kidney disease. _h[electronic resource] |
| 260 |
_bKidney international _cJan 1992 |
||
| 300 |
_a206-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a6-Ketoprostaglandin F1 alpha _xurine |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aEnalapril _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlomerular Filtration Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aKallikreins _xurine |
| 650 | 0 | 4 | _aLisinopril |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPolycystic Kidney, Autosomal Dominant _xcomplications |
| 650 | 0 | 4 |
_aRenal Circulation _xdrug effects |
| 650 | 0 | 4 |
_aRenin _xblood |
| 650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
| 700 | 1 | _aMacnicol, A M | |
| 700 | 1 | _aAllan, P L | |
| 700 | 1 | _aWright, A F | |
| 773 | 0 |
_tKidney international _gvol. 41 _gno. 1 _gp. 206-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/ki.1992.28 _zAvailable from publisher's website |
| 999 |
_c1324000 _d1324000 |
||